Home Healthcare Biotechnology Wound Care Biologics Market

Wound Care Biologics Market Size, Share & Trends Analysis Report By Product (Biological Skin Substitutes, Topical Agents), By Wound Type (Ulcers, Burns, Surgical & Traumatic Wounds), By End-User (Hospitals, Ambulatory Surgical Centers, Burn Centers) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 30, 2026 | Author: Jay Mehta | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Wound Care Biologics Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Biological Skin Substitutes
      1. Human Donor Tissue-derived Products
      2. Acellular Animal-derived Products
      3. Biosynthetic Products
    2. Topical Agents
  2. Wound Care Biologics Market, By Wound Type 2022-2034 (USD MILLION/ Units)
    1. Ulcers
      1. Diabetic Foot Ulcers
      2. Venous Ulcers
      3. Pressure Ulcers
      4. Other Ulcers
    2. Burns
    3. Surgical & Traumatic Wounds
  3. Wound Care Biologics Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Ambulatory Surgical Centers
    3. Burn Centers
  4. Regional Wound Care Biologics Market
    1. North America
      1. North America Wound Care Biologics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
      2. North America Wound Care Biologics Market By Wound Type 2022-2034 (USD MILLION/ Units)
        1. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        2. Burns
        3. Surgical & Traumatic Wounds
      3. North America Wound Care Biologics Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Burn Centers
      4. U.S.
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      5. Canada
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
    2. Europe
      1. Europe Wound Care Biologics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
      2. Europe Wound Care Biologics Market By Wound Type 2022-2034 (USD MILLION/ Units)
        1. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        2. Burns
        3. Surgical & Traumatic Wounds
      3. Europe Wound Care Biologics Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Burn Centers
      4. U.K.
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      5. Germany
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      6. France
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      7. Spain
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      8. Italy
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      9. Russia
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      10. Nordic
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      11. Benelux
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      12. Rest of Europe
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
    3. APAC
      1. APAC Wound Care Biologics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
      2. APAC Wound Care Biologics Market By Wound Type 2022-2034 (USD MILLION/ Units)
        1. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        2. Burns
        3. Surgical & Traumatic Wounds
      3. APAC Wound Care Biologics Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Burn Centers
      4. China
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      5. Korea
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      6. Japan
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      7. India
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      8. Australia
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      9. Taiwan
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      10. South East Asia
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      11. Rest of Asia-Pacific
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
    4. Middle East and Africa
      1. Middle East and Africa Wound Care Biologics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
      2. Middle East and Africa Wound Care Biologics Market By Wound Type 2022-2034 (USD MILLION/ Units)
        1. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        2. Burns
        3. Surgical & Traumatic Wounds
      3. Middle East and Africa Wound Care Biologics Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Burn Centers
      4. UAE
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      5. Turkey
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      6. Saudi Arabia
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      7. South Africa
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      8. Egypt
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      9. Nigeria
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      10. Rest of MEA
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
    5. LATAM
      1. LATAM Wound Care Biologics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
      2. LATAM Wound Care Biologics Market By Wound Type 2022-2034 (USD MILLION/ Units)
        1. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        2. Burns
        3. Surgical & Traumatic Wounds
      3. LATAM Wound Care Biologics Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Burn Centers
      4. Brazil
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      5. Mexico
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      6. Argentina
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      7. Chile
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      8. Colombia
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
      9. Rest of LATAM
        1. Biological Skin Substitutes
          1. Human Donor Tissue-derived Products
          2. Acellular Animal-derived Products
          3. Biosynthetic Products
        2. Topical Agents
        3. Ulcers
          1. Diabetic Foot Ulcers
          2. Venous Ulcers
          3. Pressure Ulcers
          4. Other Ulcers
        4. Burns
        5. Surgical & Traumatic Wounds
        6. Hospitals
        7. Ambulatory Surgical Centers
        8. Burn Centers
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.